Single Cell Genome Sequencing Market to Grow with a CAGR of 15.95% Globally through 2028
Increase in the incidence of chronic disease and increase in the aging
population is expected to drive the Global Single Cell Genome Sequencing Market
growth in the forecast period, 2024-2028.
According to TechSci Research report, “Single Cell
Genome Sequencing Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Single
Cell Genome Sequencing Market stood at USD 2.27 Billion in 2022 and is
anticipated to grow with a CAGR of 15.95% in the forecast period, 2024-2028. The
awareness among individuals regarding Single Cell Genome Sequencing has led to
favorable market conditions for the global Single Cell Genome Sequencing
market. Several factors contribute to the growth of various Single Cell Genome
Sequencing products.
The use of single-cell genome sequencing in clinical
and diagnostic applications is another significant driver. This technology has
the potential to revolutionize personalized medicine by allowing the
identification of specific genetic mutations and variations in individual cells.
It is essential for diagnosing and monitoring diseases, understanding the
development of cancer, and tailoring treatments to individual patients. The
increasing demand for more accurate and personalized medical interventions is
propelling the growth of this market.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Single Cell Genome Sequencing Market”
Ongoing technological innovations in the field of
genomics, particularly in the sequencing technologies and bioinformatics tools
used for single-cell sequencing, are driving market growth. Advances in
sequencing platforms, such as single-cell RNA sequencing, have made the process
more efficient, cost-effective, and accessible. Additionally, improvements in
data analysis and bioinformatics tools have enhanced the ability to extract
meaningful insights from single-cell data, further fueling the adoption of single-cell
genome sequencing.
In September 2023, Novogene announced
that it has signed a strategic partnership agreement with the Chinese Academy
of Sciences (CAS) to collaborate on the development and commercialization of
new genomic technologies.
Increased investments and funding from government
agencies, private sector companies, and research institutions have
significantly contributed to the growth of the single-cell genome sequencing
market. Funding supports research, development, and commercialization efforts,
making technology more accessible and affordable. As governments and
organizations recognize the potential of single-cell sequencing in various
fields, they are allocating resources to advance its applications and
capabilities.
In today's fast-paced world, single-cell genome
sequencing allows for personalized treatment. By analyzing the unique genetic
makeup of individual cells, it enables tailored medical interventions, ensuring
that patients receive the most effective and targeted therapies. This minimizes
trial-and-error in treatments, resulting in quicker recovery and better
outcomes. Cancer is a rapidly progressing disease, and timely and accurate
diagnosis is crucial. Single-cell genome sequencing helps in early cancer detection,
monitors disease progression, and identifies genetic mutations linked to
cancer. This is vital in making swift treatment decisions, including the use of
targeted therapies. In the fast-paced pharmaceutical industry, single-cell
sequencing accelerates drug development. It allows researchers to identify
potential drug targets, evaluate drug efficacy at the single-cell level, and
stratify patients for clinical trials. This speeds up the development and
approval of new drugs. In the face of rapidly spreading infectious diseases,
single-cell sequencing helps track pathogens and their mutations. This
information is crucial for developing vaccines, antiviral drugs, and
understanding how diseases evolve. Mental health is an urgent concern in
today's world. Single-cell genome sequencing is used to study the genetic basis
of neurological disorders. It provides insights into brain cell diversity and
disease mechanisms, paving the way for quicker advancements in mental health
treatment.
The growing genomic research has paved the way for
emerging fields such as single-cell transcriptomics and epigenomics.
Single-cell RNA sequencing, for instance, enables the measurement of gene
expression at the single-cell level, providing insights into cellular function.
Epigenomics explores epigenetic modifications that regulate gene expression and
is vital for understanding how genes are turned on and off in individual cells.
In recent times, Single-cell genome sequencing is
pivotal in the current era of personalized healthcare. It enables healthcare
professionals to tailor treatments to an individual's unique genetic makeup.
This results in more effective and targeted therapies, minimizing adverse
effects and optimizing patient outcomes. Understanding the genetic variations
within tumors is crucial in cancer research. Single-cell genome sequencing
allows for a detailed analysis of cancer cell populations, helping researchers
identify the genetic mutations responsible for tumor growth. This knowledge
leads to the development of more effective cancer therapies. Early diagnosis is
a cornerstone of modern healthcare. Single-cell sequencing is increasingly used
in early disease detection, especially in cases like cancer, where identifying
genetic abnormalities at the single-cell level can lead to early intervention
and better prognosis. However, the Cost and Accessibility may hinder market
growth. Moreover, challenges related to Data Integration and Interpretation and
Regulatory and Ethical Considerations may pose obstacles to the Single Cell
Genome Sequencing market in the near future.
The Global Single Cell Genome Sequencing Market is
segmented into product type, technology, workflow, disease area, application, end-user, regional
distribution, and company.
Based on its product, the Instruments segment has
emerged as the predominant market leader, The development of advanced
sequencing platforms, such as droplet-based systems and microfluidic
technologies, has been a driving force in the Instruments segment's dominance.
These platforms allow for the simultaneous sequencing of thousands of individual
cells, making single-cell sequencing more efficient and cost-effective. Instruments
that offer high throughput are in high demand, as they enable researchers to analyze
a large number of cells in a shorter timeframe. This is crucial for
comprehensive studies and large-scale projects, particularly in clinical and
pharmaceutical research. Modern instruments are capable of handling multi-omics
data from single cells, which is becoming increasingly important in genomics
research. The ability to simultaneously analyze genomics, transcriptomics,
epigenomics, and proteomics data from individual cells enhances the value of
these instruments.
Based on region, North America segment is expected to
grow during the forecast period. The predominant position of North
America can be ascribed to a range of factors. These encompass the growing
prevalence of cancer and chronic diseases in the region, ongoing technological
advancements, and substantial research and development initiatives by North
American companies. Furthermore, the proliferation of genomic clinics in the
area has further reinforced its leadership in the market.
The Asia-Pacific market is poised to be the
fastest-growing market, offering lucrative growth opportunities for Single Cell
Genome Sequencing players during the forecast period. Factors such as the key
factors fueling growth is the expanding elderly population, which is resulting
in a higher incidence of chronic illnesses among patients. Furthermore, the
region is expected to experience notable improvements in healthcare
infrastructure, driven by the endeavors of emerging nations to bolster their
economies.
Major companies operating in Global Single Cell
Genome Sequencing Market are:
- Bio-Rad Laboratories Inc
- 10x Genomics Inc
- Novogene Co. Ltd
- BGI Genomics Co Ltd.
- Illumina, Inc.
- Oxford Nanopore Technologies Plc
- Pacific Biosciences Laboratories Inc
- Thermo Fisher Scientific, Inc.
- QIAGEN GmbH
- F. Hoffmann-La-Roche Ltd
Download Free Sample Report
Customers can also request for 10% free customization
on this report
“The Advancements in Genomic Research and increasing Clinical
and Diagnostic Applications are key drivers of the Single Cell Genome
Sequencing market. In recent years, the Continuous improvement in sequencing
platforms, sample preparation, and data analysis tools make single-cell genome
sequencing more accessible, cost-effective, and accurate. Moreover, the growing
consumer emphasis on preventative healthcare products has enhanced production
and marketing efforts. To meet the demands of the market, manufacturers are
increasingly incorporating cutting-edge technologies with high production
efficiency. Rising consumer acceptance and continuous product innovation will
further ensure the growth of the Single Cell Genome Sequencing market in the
coming years.,” said Mr. Karan Chechi, Research Director with TechSci Research,
a research-based management consulting firm.
“Global Single Cell Genome Sequencing Market – Global
Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 Segmented
By Product Type (Instruments, Reagents), By Technology (NGS, PCR, qPCR,
Microarray, MDA), By Workflow (Genomic Analysis, Single Cell Isolation, Sample
Preparation), By Disease Area (Cancer, Immunology, Prenatal Diagnosis,
Neurobiology, Microbiology, Others), By Application (Circulating Cells, Cell
Differentiation/Reprogramming, Genomic Variation, Subpopulation
Characterization, Others), By End-User (Academic & Research Laboratories,
Biotechnology & Biopharmaceutical Companies, Clinics, Others), By Region,
Competition”, has evaluated the future growth potential of Global Single Cell Genome
Sequencing Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Single Cell Genome
Sequencing Market.
Contact Us-
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
M:
+13322586602
Email: [email protected]
Website: www.techsciresearch.com